Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study

BackgroundT1 imaging based on pixel-wise quantification of longitudinal relaxation has the potential to differentiate between normal and abnormal myocardium. The accuracy of T1 measurement has not been established nor systematically tested in the presence of health and disease.MethodsIntra-observer, inter-observer and inter-study reproducibility of T1 imaging was assessed in subjects with left ventricular hypertrophy (LVH, n = 25) or dilated cardiomyopathy (DCM, n = 43). Thirty-eight subjects with low-pretest likelihood of cardiomyopathy served as a control group. T1 values were acquired in a single mid-ventricular short axis slice using modified Look-Locker imaging prior and after the application of gadolinium contrast at 1.5 and 3 T. Analysis was performed with regions of interest (ROI) placed conservatively within the septum or to include the whole short axis (SAX) myocardium.ResultsIntra-observer, inter-observer and inter-study repeated measurements within the septum showed smaller mean differences and narrower 95% confidence intervals than repeated short axis ROI measurements. Native T1 values were higher in septal ROIs compared with SAX values at both field strengths (1.5 T: 976 ± 37 vs. 952 ± 41, p < 0.01; 3 T: 1108 ± 67 vs. 1087 ± 60, p < 0.01). Native T1 values revealed significant mean differences between controls and patients with LVH for both septal (1.5 T: 26 ± 9, p < 0.01; 3 T: 50 ± 13, p < 0.01) and SAX ROIs (1.5 T: 19 ± 11, p < 0.05; 3 T: 47 ± 19, p < 0.05) with greater differences observed at 3 T versus 1.5 T field strength. Native T1 values revealed significant mean differences between controls and patients with DCM for septal ROI (1.5 T: 29 ± 15, p < 0.05; 3 T: 55 ± 16, p < 0.01) at both 1.5 T and 3 T, but only for SAX ROIs at 3 T (49 ± 17, p < 0.01). There were no significant differences in post-contrast T1 values or partition coefficient (λ) between controls and patients.ConclusionConservative septal ROI T1 measurement is a robust technique with excellent intra-observer, inter-observer and inter-study reproducibility for native and post-contrast T1 value and partition coefficient measurements. Moreover, native septal T1 values reveal the greatest difference between normal and abnormal myocardium, which is independent of geometrical alterations of cardiac chamber and wall thickness. We propose the use of native T1 measurements using conservative septal technique as the standardized approach to distinguish health from disease assuming diffuse myocardial involvement.

[1]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[2]  P. Kellman,et al.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.

[3]  Stefan Neubauer,et al.  Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[4]  David A Bluemke,et al.  T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA , 2012, Journal of Cardiovascular Magnetic Resonance.

[5]  E. Nagel,et al.  EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.

[6]  J. Schulz-Menger,et al.  T1 mapping in patients with acute myocardial infarction. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[7]  V. Puntmann How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease , 2009, Postgraduate Medical Journal.

[8]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[9]  M. Robson,et al.  Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.

[10]  Stefan Neubauer,et al.  Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.

[11]  E. Nagel,et al.  Usefulness of Cardiac Magnetic Resonance in Early Assessment of Cardiomyopathies: Myocardial Fibrosis Is a Common Denominator , 2012, Current Cardiovascular Imaging Reports.

[12]  David A Bluemke,et al.  T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region , 2012, Journal of Cardiovascular Magnetic Resonance.

[13]  R. Boellaard,et al.  Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  S. Plein,et al.  Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction , 2007, Magnetic resonance in medicine.

[15]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience , 2012, Journal of Cardiovascular Magnetic Resonance.

[16]  Reza Razavi,et al.  Interleaved T1 and T2 relaxation time mapping for cardiac applications , 2009, Journal of magnetic resonance imaging : JMRI.

[17]  B R Rosen,et al.  Assessment of myocardial ischemia with proton magnetic resonance: effects of a three hour coronary occlusion with and without reperfusion. , 1985, Circulation.

[18]  David M Higgins,et al.  Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.

[19]  Reza Razavi,et al.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.

[20]  P. Kellman,et al.  Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[21]  K P Pruessmann,et al.  Sensitivity encoded cardiac MRI. , 2001, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[22]  Andreas Greiser,et al.  Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.

[23]  Eckart Fleck,et al.  Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. , 2013, European heart journal cardiovascular Imaging.

[24]  Roderic I Pettigrew,et al.  Effect of Gd‐DTPA‐BMA on blood and myocardial T1 at 1.5T and 3T in humans , 2006, Journal of magnetic resonance imaging : JMRI.

[25]  Sandeep N. Gupta,et al.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.

[26]  D. Bluemke,et al.  Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials , 2012, Journal of Cardiovascular Magnetic Resonance.

[27]  E. Nagel,et al.  Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.